Praxis Precision Medicines (PRAX) Misses Q1 EPS by 284c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($2.84). Revenue for the quarter came in at $430 thousand.

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Albemarle names Max Hood as chief accounting officer
• Dollar stores see mixed outlook ahead of earnings next week, Gordon Haskett comments